CCNTACentessa Pharmaceuticals PLC ADR

Centessa Pharmaceuticals PLC ADR

CNTA

1D · 1W · 1M · 3M · YTD · 1Y · 5Y · AllLive CNTA chart

  • Mkt cap

    $6.15B

  • EV/Sales

    413.4

  • P/E ratio

    N/A

  • FY2025 Revenue

    $15.00M

  • EPS (9mo ended 2025-09-30)

    $-0.98

  • Gross Margin (FY2025)

    N/A

  • Profit Margin (FY2025)

    -1316.88%

  • Beta

    1.14

  • Div yield

    N/A

  • Sector

    Healthcare

Live CNTA terminalLician Pro · $19.99/mo or $149/yrPeer financials on ProAPI free 100/dayCompare AAPL vs MSFT

CNTA — Centessa Pharmaceuticals PLC ADR · rev $15.0M

CNTA Key Statistics

  • Market Cap: $6.15B

Centessa Pharmaceuticals PLC ADR latest statements (FY2025)

Latest cached year on this hub. Full CNTA income, balance, and cash tables.

  • Revenue$15.0M
  • Net Income-$197.5M
  • Total Assets$687.5M
  • Total Debt$110.1M
  • Free Cash Flow-$194.2M

† Total Debt: Derived from long-term debt only (no total or short-term debt stored).

CNTA recent filings

CNTA FAQ

What industry is CNTA in?

Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company in the Healthcare sector.

What are CNTA's latest revenue and net income?

Latest cached Centessa Pharmaceuticals PLC ADR (CNTA) revenue for Dec 31, 2025 was $15.0M. Net income was -$197.5M. Statements: https://lician.com/financials/cnta

What is CNTA's market cap?

Centessa Pharmaceuticals PLC ADR (CNTA) market capitalization is $6.15B on the latest cached snapshot.

What is the latest CNTA SEC filing?

The latest cached CNTA filing is 8-K · Jun 24, 2026. Filings: https://lician.com/sec/cnta

Live CNTA terminal loads when you scroll near this section.